#macularedema — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #macularedema, aggregated by home.social.
-
https://www.europesays.com/ch/107672/ CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD) #Archway #EuropeanMedicinesAgency #EuropeanUnion #EyeDiseases #EyeInjections #MacularDegeneration #MacularEdema #PortDeliveryPlatform #ranibizumab #Roche #Susvimo #TreatmentOptions
-
https://www.europesays.com/ch/107616/ CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD) #Archway #EuropeanMedicinesAgency #EuropeanUnion #EyeDiseases #EyeInjections #MacularDegeneration #MacularEdema #PortDeliveryPlatform #ranibizumab #Roche #Susvimo #TreatmentOptions
-
https://www.europesays.com/ch/81555/ Roche heads to FDA as phase 3 eye disease trials yield mixed data #biotech #ClinicalData #ClinicalTrialData #FierceBiotechHomepage #MacularEdema #Roche
-
https://www.europesays.com/ch/60095/ Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026 #DiabeticMacularEdema #DME #MacularDegeneration #MacularEdema #ophthalmology #ranibizumab #RealWorldData #RetinalConditions #RetinalVeinOcclusion #Roche
-
https://www.europesays.com/ch/59698/ Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026 #DiabeticMacularEdema #DME #MacularDegeneration #MacularEdema #ophthalmology #ranibizumab #RealWorldData #RetinalConditions #RetinalVeinOcclusion #Roche
-
https://www.europesays.com/ch/59195/ Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026 #DiabeticMacularEdema #DME #MacularDegeneration #MacularEdema #ophthalmology #ranibizumab #RealWorldData #RetinalConditions #RetinalVeinOcclusion #Roche